Company profile

EnsoData

Remote Patient Monitoring & Wearables

Company profile

About EnsoData

EnsoData is a health AI company specializing in waveform intelligence and sleep diagnostics. The company has developed an AI-driven ecosystem that powers sleep medicine from diagnosis through long-term patient care, serving over 500 sleep clinics and analyzing more than 2.8 million sleep studies. EnsoData's flagship products include EnsoHST, an FDA-cleared multi-night home sleep test that enables scalable sleep disorder diagnosis; EnsoSleep, an AI-assisted sleep scoring solution that automates polysomnography (PSG) and home sleep apnea test (HSAT) analysis; EnsoHub, a unified platform for accessing and reviewing AI-scored sleep studies; and Therapy Track for long-term therapy monitoring. The company's technology is built on one of the largest waveform databases in the world, enabling it to extract clinical insights from physiological signals. EnsoData's mission is to harness data to make healthcare more accurate, efficient, and affordable, with a particular focus on addressing the estimated 54 million Americans and 936 million people globally who suffer from sleep apnea, 80% of whom remain undiagnosed. Beyond sleep, the company's research aims to find hidden intelligence in waveforms to diagnose, monitor, and intercept various disease states including heart disease, diabetes, mental health disorders, seizure disorders, and neurodegenerative conditions.

Company description EnsoData official website

Primary marketRemote Patient Monitoring & Wearables
Commercial modelCommercial information available on request
Company presenceLinkedIn X
Work at EnsoData?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Alzheimer's
  • Atrial fibrillation
  • Dementia
  • Diabetes
  • Heart disease
  • Mental health disorders
  • Obstructive sleep apnea (OSA)
  • Parkinson's
  • Seizure disorders
  • Sleep apnea
  • Sleep-disordered breathing
  • Stroke

Who it serves

  • Health systems
  • Hospital sleep centers
  • Sleep clinics
  • Sleep medicine providers

Deployment & integration

Cloud Saas · Hybrid deployment with recorded integration context.

Geographic context

MarketsUnited States
Company sourceOfficial website

Company milestones

Platform expansion

Analyzed 2.8+ million sleep studies, serving 500+ sleep clinics, supporting 100,000+ patients monthly. Four FDA clearances obtained. Expanded product line to include full diagnostic-to-therapy pathway.

Partnerships

Recorded partners

  • Advanced Sleep Management
  • CHI St. Joseph
  • Chicago ENT/Chicago Sleep Center
  • Rush University Sleep Center
  • Sleep Associates of Connecticut
  • UC Davis Medical Center
  • University of Washington School of Medicine
  • Valley Sleep Center
  • Western Sleep Medicine

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

EnsoHST

FDA-cleared, multi-night home sleep test for scalable sleep disorder diagnosis

Device · HybridCompany source

EnsoHub

Unified platform to access, review and edit all AI-scored sleep studies

Platform · Cloud SaaSCompany source

EnsoSleep

FDA-cleared AI-assisted sleep scoring and analysis solution

Software · Cloud SaaSCompany source

Therapy Track

Long-term therapy monitoring extending the sleep care pathway

Software · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

97% patient success rate

EnsoHST home sleep testing

>92% sensitivity for sleep apnea

EnsoHST diagnostic accuracy

5.5 minute average difference in sleep time

Comparison to traditional methods

30% growth in HSAT program

Valley Sleep Center case study

Reduced scoring time and backlog elimination

EnsoSleep automation for RPSGTs

Advanced Sleep Management

Controlling quality and eliminating inconsistencies in reporting

40 physicians no longer complain about inconsistencies, improved efficiency and quality

CHI St. Joseph

Freeing up time to enhance patient care and develop new programs

Time freed to enhance patient care, develop new programs, build physician relationships, improve quality reporting

Chicago ENT/Chicago Sleep Center

Enabling comparative data analysis across baseline and therapy nights

Ability to run baseline followed by therapy night with comparative data analysis

Rush University Sleep Center

Eliminating study backlog and reducing patient wait times

Cutting into backlog, much shorter patient wait times for results

Sleep Associates of Connecticut

Improving patient testing and diagnostic workflow with cloud-based platform

Improved patient testing and diagnostic workflow, sleep lab running more smoothly

Sleep Data

Reducing costs and processing time while improving scalability

Decreased costs, decreased processing time, improved physician buy-in regarding accuracy, increased scalability

Valley Sleep Center

Moving beyond legacy HSAT solutions to expand patient care and add new locations

30% growth in HSAT program, added cash-pay option, expanded to new locations without increasing staff

Western Sleep Medicine

Improving turnaround time and patient setup efficiency

Great and efficient turnaround time, smooth and easy patient setup process

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Chris Fernandez

Chris Fernandez

Co-Founder, Executive Chairman, & CRO

LinkedIn

Brock Hensen

COO

Bobby Cockrill

CCO

06 · Company updates

Updates from EnsoData

Recent articles published on EnsoData's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Remote Patient Monitoring & Wearables

Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon